These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Sebastiani GD; Galeazzi M; Tincani A; Scorza R; Mathieu A; Passiu G; Morozzi G; Piette JC; Cervera R; Houssiau F; Smolen J; Fernandez Nebro A; De Ramon E; Goral AJ; Papasteriades C; Ferrara GB; Carcassi C; Bellisai F; Marcolongo R; Lupus; 2003; 12(7):560-3. PubMed ID: 12892399 [TBL] [Abstract][Full Text] [Related]
45. Elevated anticardiolipin antibodies in autoimmune haemolytic anaemia irrespective of underlying systemic lupus erythematosus. Lang B; Straub RH; Weber S; Röther E; Fleck M; Peter HH Lupus; 1997; 6(8):652-5. PubMed ID: 9364424 [TBL] [Abstract][Full Text] [Related]
46. The role of antiphospholipid autoantibodies in the cognitive deficits of patients with systemic lupus erythematosus. Coín MA; Vilar-López R; Peralta-Ramírez I; Hidalgo-Ruzzante N; Callejas-Rubio JL; Ortego-Centeno N; Pérez-García M Lupus; 2015 Jul; 24(8):875-9. PubMed ID: 25697771 [TBL] [Abstract][Full Text] [Related]
47. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications. Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474 [TBL] [Abstract][Full Text] [Related]
48. Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus. Steens SC; Bosma GP; Steup-Beekman GM; le Cessie S; Huizinga TW; van Buchem MA Arthritis Res Ther; 2006; 8(2):R38. PubMed ID: 16469116 [TBL] [Abstract][Full Text] [Related]
52. Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus. Yoshio T; Masuyama J; Ikeda M; Tamai K; Hachiya T; Emori T; Mimori A; Takeda A; Minota S; Kano S J Rheumatol; 1995 Sep; 22(9):1681-7. PubMed ID: 8523345 [TBL] [Abstract][Full Text] [Related]
53. Clinical presentations and vascular histopathology in autopsied patients with systemic lupus erythematosus and anticardiolipin antibodies. Sipek-Dolnicar A; Hojnik M; Bozic B; Vizjak A; Rozman B; Ferluga D Clin Exp Rheumatol; 2002; 20(3):335-42. PubMed ID: 12102469 [TBL] [Abstract][Full Text] [Related]
54. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792 [TBL] [Abstract][Full Text] [Related]
55. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients. Jouhikainen T; Julkunen H; Vaarala O; Leirisalo-Repo M; Stephansson E; Vahtera E; Palosuo T; Myllylä G Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816 [TBL] [Abstract][Full Text] [Related]
56. BF*F allotype of the alternative pathway of complement: A marker of protection against the development of antiphospholipid antibodies in patients with systemic lupus erythematosus. Picceli VF; Skare TL; Nisihara RM; Nass FR; Messias-Reason IT; Utiyama SR Lupus; 2016 Apr; 25(4):412-7. PubMed ID: 26537423 [TBL] [Abstract][Full Text] [Related]
57. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Mikdashi J; Handwerger B Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927 [TBL] [Abstract][Full Text] [Related]